Kazia Therapeutics Limited

ASX:KZA
Deleted on 2023-11-18 00:30:04

Kazia Therapeutics Limited

ASX:KZA
Deleted on 2023-11-18 00:30:04
$0.080 (+9.6%)
Last close price
#647
Rank
1
Held by
1
Followers
Reports My Report Forum Investors
Top member reports
Consensus
Figgy
Company Report
Last edited 3 years ago
PerformanceCommunity EngagementCommunity Endorsement
ranked
#298
Performance (39m)
-3.5% pa
Followed by
3
Follow Unfollow
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
Become a member
#Bull Case
stale
Figgy
Added 3 years ago
View author's company report

Early results but paxalisib shows some promise to improve survival in glioblastoma over current standard of care. KZA has patients enrolling in the industry standard gbm trial. Despite the volatility over the last year, i believe management when they say newsflow over the next two years will be good